engineered TILs expressing anti PD-1 antibody (Shanghai Cell Therapy Group/Shanghai Cell Therapy Research Institute)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameengineered TILs expressing anti PD-1 antibody (Shanghai Cell Therapy Group/Shanghai Cell Therapy Research Institute)
Drug Alias Nameautologous tumor-infiltrating lymphocyte (Shanghai Cell Therapy Group/Shanghai Cell Therapy Research Institute)PD1-TIL
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionProgrammed cell death protein 1 modulators
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Cell Therapy Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Cell Therapy Research InstituteShanghai Cell Therapy Group Co Ltd
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A